Business Description

Acadia Healthcare Company Inc. is a publicly traded provider of specialty behavioral health services in the United States, founded in 1987 and headquartered in Franklin, Tennessee, United States. The company operates over 180 facilities that deliver inpatient psychiatric care, residential addiction treatment, and outpatient mental health services. Under Interim CEO Kevin Truitt, Acadia emphasizes integrated treatment models and digital health innovations. This diversified approach positions the company to effectively navigate regulatory pressures and capitalize on growth opportunities in the evolving healthcare market.

Everything on Acadia Healthcare Company Inc.

Revenue (FY2025) $3.31B
YoY growth +5.0%
Operating margin -28.2%
Direction Expanding
Gross margin 100.0%
Net margin -33.0%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Reeve B. Waud — Chairman of the Board View full profile ↗ Debra K. Osteen — Chief Executive Officer and Director View full profile ↗ Michael J. Fucci — Director (Class III Nominee) View full profile ↗ Patrice A. Harris, M.D., M.A. — Director (Class III Nominee) View full profile ↗ Daniel J. Cancelmi — Director (Class III Nominee) View full profile ↗ E. Perot Bissell — Director (Class I) View full profile ↗ Vicky B. Gregg — Director (Class I) View full profile ↗ Jason R. Bernhard — Director (Class II) View full profile ↗ William F. Grieco — Director (Class II) View full profile ↗ R. David Kelly — Director (Class II) View full profile ↗ Todd S. Young — Chief Financial Officer View full profile ↗ Brian P. Farley — Executive Vice President, General Counsel and Secretary View full profile ↗ Christopher H. Hunter — Former Chief Executive Officer and Director View full profile ↗ Nasser Khan, M.D. — Former Chief Operating Officer View full profile ↗ Heather Dixon — Former Chief Financial Officer View full profile ↗ Timothy Sides — Former Interim Chief Financial Officer View full profile ↗

Share Repurchase Program

Total authorized
$300.0 million
Remaining (as of December 31, 2025)
$250.0 million
Latest FY repurchased
$50.4 million

Customer Concentration

For the year ended December 31, 2025, the Company received 57.7% of revenue from Medicaid, 24.6% from commercial payors, 14.3% from Medicare and 3.4% from other payors. No facility accounted for more than 4% of revenue, and no state or U.S. territory accounted for more than 14% of revenue, for the year ended December 31, 2025; revenue from Pennsylvania, Tennessee and California represented approximately 13%, 10% and 8% of total revenue, respectively.

Recent SEC Filings

2026-05-18 Other event View filing ↗
2026-05-06 Shareholder vote results View filing ↗
2026-04-29 Reported quarterly results (+1 more) View filing ↗
2026-04-23 Leadership change (directors/officers) (+1 more) View filing ↗
2026-03-12 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-25 Reported quarterly results (+1 more) View filing ↗
2026-01-23 Leadership change (directors/officers) View filing ↗
2026-01-20 Leadership change (directors/officers) (+1 more) View filing ↗
2026-01-13 Reported quarterly results (+1 more) View filing ↗
2025-12-02 Regulation FD disclosure View filing ↗
2025-11-10 Regulation FD disclosure View filing ↗
2025-11-05 Reported quarterly results (+1 more) View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

You're subscribed.

Thanks for signing up.